课题基金 / 基金详情

MONOCLONAL ANTIBODY

MONOCLONAL ANTIBODY
单克隆抗体
批准号:
8182202
负责人:
LISA K. DENZIN
金额:
$16.51万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
关键词:

项目摘要

项目成果

LISA K. DENZIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Monoclonal Antibody Core Facility (MACF) provides the following four high quality services not only at a reasonable cost to investigators but also in a timely manner. 1. The generation of new MAbs / hybridomas to a specific antigen of interest. 2. MAb production (in vitro), purification and modification (including conjugation to fluorphores, biotion and enzymes and the fragmentation of MAbs). 3. Mycoplasma testing of tissue culture samples. 4. In vitro production of recombinant/secreted proteins. Monoclonal antibodies (MAbs) are essential tools used in most if not all fields of biomedical research, in the diagnosis of diseases, and in the treatment of diseases such as infections and cancer. The goal of the MACF is to support the research interests of MSKCC investigators by providing key services related to the production, purification and use of MAbs. Over the last 5 years demand for the MACF services has remained consistently high. From July 2005 through July 2006, 61 investigators from 9 out of 10 programs placed orders with the facility for any combination of the services noted above.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Molecular Mechanisms by which the Paf Oncogene Mediates Hematopoiesis
The Molecular Mechanisms by which the Paf Oncogene Mediates Hematopoiesis
The Molecular Mechanisms by which the Paf Oncogene Mediates Hematopoiesis
MONOCLONAL ANTIBODY
海外基金